abrdn Blue Chip International Portfolio, Series 4 Blue Chip Dividend Portfolio, Series 12 Blue Chip Growth Portfolio, Series 38 Tekla Medical Science Innovation Portfolio, Series 6 US Capital Strength Portfolio, Series 26 REFERENCE TRUST AGREEMENTReference Trust Agreement • May 17th, 2023 • Guggenheim Defined Portfolios, Series 2315
This Reference Trust Agreement dated as of May 17, 2023, between Guggenheim Funds Distributors, LLC, as Depositor, and The Bank of New York Mellon, as Trustee, sets forth certain provisions in full and incorporates other provisions by reference to the document entitled “Standard Terms and Conditions of Trust For Series Formed on or Subsequent to December 18, 2001” (herein called the “Standard Terms and Conditions of Trust”), and such provisions as are set forth in full and such provisions as are incorporated by reference constitute a single instrument. All references herein to Articles and Sections are to Articles and Sections of the Standard Terms and Conditions of Trust.
Portfolio Support and License AgreementSupport and License Agreement • May 17th, 2023 • Guggenheim Defined Portfolios, Series 2315 • Illinois
This Portfolio Support and License Agreement (the “Agreement”), dated as of May 2, 2023, is made by and between abrdn Inc., a Delaware corporation (“Consultant/Licensor”), and Guggenheim Funds Distributor, LLC., (“GFD” or “Licensee”) as sponsor to, abrdn Blue Chip International Portfolio, Series 4 (the “Trust”).
Portfolio Support and License AgreementAnd License Agreement • May 17th, 2023 • Guggenheim Defined Portfolios, Series 2315 • Illinois
This Agreement, dated as of November 17th, 2020, is made by and between Tekla Capital Management, LLC, a Delaware limited liability company (“Consultant/Licensor”), and Guggenheim Funds Distributor, LLC., (“GFD” or “Licensee”) as sponsor to the TEKLA MEDICAL SCIENCE INNOVATION PORTFOLIO, 001, (the “Trust”). For the avoidance of doubt, this Agreement covers only this Trust. Consultant/Licensor has no obligation to provide a license or services with respect to any additional trust. Any additional trust would require a separate agreement between Consultant/Licensor and GFD.
